Literature DB >> 34633840

Mutations in the HIV-1 3'-Polypurine Tract Can Confer Dolutegravir Resistance.

José G Dekker1, Bep Klaver1, Ben Berkhout1, Atze T Das1.   

Abstract

Entities:  

Keywords:  antiretroviral resistance; dolutegravir; human immunodeficiency virus

Mesh：

Substances：

Year:  2021        PMID： 34633840      PMCID： PMC8765316          DOI： 10.1128/AAC.01027-21

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.938


× No keyword cloud information.
  10 in total

1.  Mutations in the HIV-1 3'-Polypurine Tract and Integrase Strand Transfer Inhibitor Resistance.

Authors:  Yuliang Wei; Nicolas Sluis-Cremer
Journal:  Antimicrob Agents Chemother       Date:  2021-05-18       Impact factor: 5.191

2.  Unique morphological alterations of the HTLV-I transformed C8166 cells by infection with HIV-1.

Authors:  J Ongrádi; H M Laird; J F Szilágyi; A Horváth; M Bendinelli
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

3.  Mutations in the HIV-1 envelope glycoprotein can broadly rescue blocks at multiple steps in the virus replication cycle.

Authors:  Rachel Van Duyne; Lillian S Kuo; Phuong Pham; Ken Fujii; Eric O Freed
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-11       Impact factor: 11.205

4.  Authentication Analysis of MT-4 Cells Distributed by the National Institutes of Health AIDS Reagent Program.

Authors:  Melissa V Fernandez; Krista A Delviks-Frankenberry; David A Scheiblin; Christine Happel; Vinay K Pathak; Eric O Freed
Journal:  J Virol       Date:  2019-11-26       Impact factor: 5.103

5.  Tax induces the recruitment of NF-kB to unintegrated HIV-1 DNA to rescue viral gene expression and replication.

Authors:  Ishak D Irwan; Bryan R Cullen
Journal:  J Virol       Date:  2021-04-21       Impact factor: 5.103

6.  HIV-1 Resistance Dynamics in Patients With Virologic Failure to Dolutegravir Maintenance Monotherapy.

Authors:  Ingeborg E A Wijting; Cynthia Lungu; Bart J A Rijnders; Marchina E van der Ende; Hanh T Pham; Thibault Mesplede; Suzan D Pas; Jolanda J C Voermans; Rob Schuurman; David A M C van de Vijver; Patrick H M Boers; Rob A Gruters; Charles A B Boucher; Jeroen J A van Kampen
Journal:  J Infect Dis       Date:  2018-07-24       Impact factor: 5.226

7.  Mutations Located outside the Integrase Gene Can Confer Resistance to HIV-1 Integrase Strand Transfer Inhibitors.

Authors:  Isabelle Malet; Frédéric Subra; Charlotte Charpentier; Gilles Collin; Diane Descamps; Vincent Calvez; Anne-Geneviève Marcelin; Olivier Delelis
Journal:  mBio       Date:  2017-09-26       Impact factor: 7.867

8.  Reply to Das and Berkhout, "How Polypurine Tract Changes in the HIV-1 RNA Genome Can Cause Resistance against the Integrase Inhibitor Dolutegravir".

Authors:  Isabelle Malet; Frédéric Subra; Clémence Richetta; Charlotte Charpentier; Gilles Collin; Diane Descamps; Vincent Calvez; Anne-Geneviève Marcelin; Olivier Delelis
Journal:  mBio       Date:  2018-05-29       Impact factor: 7.867

9.  How Polypurine Tract Changes in the HIV-1 RNA Genome Can Cause Resistance against the Integrase Inhibitor Dolutegravir.

Authors:  Atze T Das; Ben Berkhout
Journal:  mBio       Date:  2018-04-10       Impact factor: 7.867

10.  Reversal of Epigenetic Silencing Allows Robust HIV-1 Replication in the Absence of Integrase Function.

Authors:  Ishak D Irwan; Heather L Karnowski; Hal P Bogerd; Kevin Tsai; Bryan R Cullen
Journal:  mBio       Date:  2020-06-02       Impact factor: 7.867
  10 in total
  2 in total

1.  Specific mutations in the HIV-1 G-tract of the 3'-polypurine tract cause resistance to integrase strand transfer inhibitors.

Authors:  Atsuko Hachiya; Mai Kubota; Urara Shigemi; Hirotaka Ode; Yoshiyuki Yokomaku; Karen A Kirby; Stefan G Sarafianos; Yasumasa Iwatani
Journal:  J Antimicrob Chemother       Date:  2022-02-23       Impact factor: 5.790

Review 2.  Multimodal Functionalities of HIV-1 Integrase.

Authors:  Alan N Engelman; Mamuka Kvaratskhelia
Journal:  Viruses       Date:  2022-04-28       Impact factor: 5.818
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.